| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |